Home
Add Document
Sign In
Create An Account
RCPath - RCC-MGP case.pptx
Recommend Documents
No documents
RCPath - RCC-MGP case.pptx
Download PDF
2 downloads
0 Views
6MB Size
Report
Comment
Dec 18, 2018 -
Female, 51 years old. ⢠Hematuria. ⢠Kidney mass, 5.5cm extending microscopically to hilar renal soft tissues. ⢠Tubular, cribiform, and solid ...
100K Genomes Project
12/18/18
1
100K Genomes Project
Dec 18, 2018
• Previous history of leiomyomatosis
100K Genomes Project
• Female, 51 years old. • Hematuria. • Kidney mass, 5.5cm extending microscopically to hilar renal soft tissues. • Tubular, cribiform, and solid growth pattern. • Desmoplastic reaction • Large cell with prominent nucleolus and eosinophilic cytoplasm • Microscopic vascular invasion. • Margins free of neoplasm (circumferential, ureteric and vascular)
Dec 18, 2018
Renal Cell Carcinoma
2
RCC case
1
100K Genomes Project
Dec 18, 2018
100K Genomes Project
Dec 18, 2018
100K Genomes Project
RCC case 12/18/18
3
4
2
100K Genomes Project
Dec 18, 2018
100K Genomes Project
Dec 18, 2018
100K Genomes Project
RCC case 12/18/18
5
6
3
12/18/18
100K Genomes Project
Dec 18, 2018
100K Genomes Project
7
100K Genomes Project
Dec 18, 2018
TUMOR TYPE: KIDNEY RENAL CELL CARCINOMA, UNCLASSIFIED
8
RCC case
4
12/18/18
100K Genomes Project
Dec 18, 2018
100K Genomes Project
Renal Cell carcinomas, unclassified vascular
9
New Phenotype of Pseudohypoxia-associated Neoplasms – Low mutation burden and solid, desmoplastic, poorly-differentiated growth
100K Genomes Project
Dec 18, 2018
Pseudohypoxia Pathways
10
RCC case
5
100K Genomes Project
12/18/18
100K Genomes Project
Dec 18, 2018
Neoangiogenesis and Tumorigenesis Promotion in Pseudohypoxia
11
RCC case
6
×
Report "RCPath - RCC-MGP case.pptx"
Your name
Email
Reason
-Select Reason-
Pornographic
Defamatory
Illegal/Unlawful
Spam
Other Terms Of Service Violation
File a copyright complaint
Description
×
Sign In
Email
Password
Remember me
Forgot password?
Sign In
Our partners will collect data and use cookies for ad personalization and measurement.
Learn how we and our ad partner Google, collect and use data
.
Agree & close